Stock Taper Revenue: $129.5 million, a 10% increase year-over-year, but a 1% decline sequentially due to seasonality in payment processing.
Adjusted EBITDA: $32.9 million, up $10.8 million year-over-year, with an adjusted EBITDA margin of 25%.
Net Income: $1.9 million, compared to $700,000 in the prior year, marking the fifth consecutive quarter of positive net income.
Total Managed Payments: $1.626 billion, with a Payment Solutions revenue rate of 2.4%.
Cash Position: Ended the quarter with $74.6 million in cash, down from $76.4 million in the previous quarter.
Operating Cash Flow: $18.3 million, up $3.5 million year-over-year; Free Cash Flow: $13.8 million, up $4.2 million year-over-year.
AccessOne: Positioned as a key growth driver, with positive feedback from clients and early wins in the market.
Provider Connect: New Network Solutions offering gaining traction, contributing to overall growth.
GLP-1 Campaign: A successful pilot study showed a 4% increase in new-to-brand prescriptions, leading to new business opportunities.
Product Development: Continued investment in AI and new features aimed at enhancing provider efficiency and patient engagement.
Revenue Outlook for Fiscal 2027: Maintained at $510 million to $520 million, including approximately $37 million from AccessOne.
Adjusted EBITDA Outlook: Also maintained at $125 million to $135 million.
AHSC Growth: Expected to remain in the mid-single-digit percentage range, with total revenue per AHSC growth anticipated in the low single-digit percentage range.
Sequential Revenue Decline: Notable decline in total revenue from the previous quarter primarily due to seasonality in payment processing.
Legacy Payment Processing: Continued reliance on this segment may pose risks given its seasonal nature.
Competitive Pressures: Ongoing competition from EHRs with integrated check-in management solutions, which may impact client acquisition and retention.
Market Dynamics: Providers are under financial strain due to changes in payer dynamics, which could affect pricing strategies and revenue growth.
AccessOne: Management expressed optimism about the acquisition and its potential to drive growth, with positive client feedback noted.
Network Solutions: Progress in business activity was highlighted, with new products resonating well in the market.
Subscription Pricing: Management is moderating pricing to support client retention and downstream revenue, with a focus on total revenue rather than individual metrics.
AI Integration: AI is seen as a transformative element in product development and operational efficiency, with ongoing investments expected to yield significant benefits.
Patient Volume Trends: No notable changes in patient volume or deductible trends were reported, indicating stability in the current environment. Overall, Phreesia reported solid financial performance with strategic initiatives aimed at growth, though challenges related to seasonality, competition, and market dynamics remain. The company maintains a cautious yet optimistic outlook for the remainder of fiscal 2027.
SOURCE: Q2 2027 EARNINGS CALL TRANSCRIPT